Zhang Liang, Wang Fang, Tashiro Syoichi, Liu Peng Ju
Department of Rehabilitation Medicine, Kyorin University Faculty of Medicine, Tokyo, Japan.
Department of Clinical Nutrition, Department of Health Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, PR China.
Adv Nutr. 2024 Dec;15(12):100330. doi: 10.1016/j.advnut.2024.100330. Epub 2024 Oct 29.
Although lifestyle interventions are recommended as the frontline therapeutic strategy for women with gestational diabetes mellitus (GDM), the optimal dietary regimen or form of exercise has yet to be definitively established. We aimed to compare the effectiveness of lifestyle therapies for GDM. Four databases (PubMed, Web of Science, EMBASE, and Cochrane Library) were systematically searched by multiple researchers for randomized controlled trials (RCTs). RCTs comparing lifestyle therapies to treat GDM with control or another treatment were included. Data extraction and synthesis were performed, estimating mean differences (MDs) or relative risk (RR) through pair-wise and network meta-analysis with a randomized or fixed-effects model when appropriate. The primary outcomes were maternal glucose control, birth weight of newborns, macrosomia and preterm birth rate, and rate of need for insulin therapy. In total, 39 trials with information obtained from 2712 women assessed 15 treatments. After sensitivity analysis, we confirmed the dietary approaches to stop hypertension (DASH) diet [MD: -11.52; 95% credible intervals (CrIs): -14.01, -9.07, very low certainty of evidence (CoE)] and low glycemic index (GI) diets (MD: -6.3; 95% CrI: -9.9, -2.7, low CoE) have shown significant advantages in fasting plasma glucose and 2-h postprandial glucose control, respectively. Furthermore, the DASH diet and resistance exercise reduced insulin requirements independently by 71% (95% CrI: 52%, 84%) and 67% (95% CrI: 48%, 85%), respectively. Additionally, both the DASH (MD: -587.6; 95% CrI: -752.12, -421.85, low CoE) and low GI diets (MD: -180.09, 95% CrI: -267.48, -94.65, low CoE) reduced birth weight significantly, with the DASH diet also demonstrating effects in reducing macrosomia by 89% (95% CrI: 53%, 98%) and lowering the cesarean section rate by 46% (95% CI: 27%, 60%). However, exercise did not affect infant outcomes. Our findings suggest that the DASH diet and low GI diet and resistance exercise may be beneficial for maternal outcomes in pregnancies with GDM. The impact on infants is primarily observed through dietary interventions. Future research, characterized by higher quality and evidence grades, is necessary to complement and substantiate our findings. This study was registered with PROSPERO as CRD 42024527587.
尽管生活方式干预被推荐为妊娠糖尿病(GDM)女性的一线治疗策略,但最佳饮食方案或运动形式尚未明确确立。我们旨在比较生活方式疗法对GDM的有效性。多位研究人员系统检索了四个数据库(PubMed、Web of Science、EMBASE和Cochrane图书馆)以查找随机对照试验(RCT)。纳入了比较生活方式疗法与对照或其他治疗来治疗GDM的RCT。进行了数据提取和综合分析,在适当情况下通过随机或固定效应模型的成对和网络荟萃分析估计平均差(MD)或相对风险(RR)。主要结局包括母体血糖控制、新生儿出生体重、巨大儿和早产率以及胰岛素治疗需求率。总共39项试验从2712名女性中获取信息,评估了15种治疗方法。经过敏感性分析,我们确认饮食预防高血压(DASH)饮食[MD:-11.52;95%可信区间(CrI):-14.01,-9.07,证据确定性(CoE)极低]和低血糖指数(GI)饮食(MD:-6.3;95% CrI:-9.9,-2.7,CoE低)分别在空腹血糖和餐后2小时血糖控制方面显示出显著优势。此外,DASH饮食和抗阻运动分别使胰岛素需求独立降低了71%(95% CrI:52%,84%)和67%(95% CrI:48%,85%)。此外,DASH饮食(MD:-587.6;95% CrI:-752.12,-421.85,CoE低)和低GI饮食(MD:-180.09,95% CrI:-267.48,-94.65,CoE低)均显著降低了出生体重,DASH饮食还显示出将巨大儿减少89%(95% CrI:53%,98%)并将剖宫产率降低46%(95% CI:27%,60%)。然而,运动并未影响婴儿结局。我们的研究结果表明,DASH饮食、低GI饮食和抗阻运动可能对患有GDM的孕妇的母体结局有益。对婴儿的影响主要通过饮食干预观察到。需要以更高质量和证据等级为特征的未来研究来补充和证实我们的发现。本研究已在PROSPERO注册,注册号为CRD 42024527587。